OIP — The Opportunity Intelligence PlatformOIP / Government Intelligence
Preparing the stored Government Intelligence discovery view.
OIP / Government Intelligence / Opportunity detail
Source: Stored live-derived Government dataCancer Prevention And Research Institute - 542
OIP derived this review page from stored live-derived Government Intelligence source records. The official source and issuing agency remain authoritative.
Opportunity Intelligence Platform is an independent service and is not affiliated with or endorsed by the U.S. Government. Official notices, amendments, attachments, eligibility requirements, funding terms, and deadlines remain under source control.
OIP scores and explanations are informational and do not guarantee eligibility, suitability, compliance, contract award, or financial outcome.
No funding amount is disclosed in the stored source fields.
2 warning(s) require review.
Objective score, derived by OIP
Publication decision: Publish with warning
Texas Regional Training Award. Texas agency grant listing. Source-listed deadline: 11/18/2026 5:00 PM (timezone unverified).
This official Texas grant listing may warrant further review; suitability has not been established.
List-level evidence only. Detailed grant documents and PDFs were not reviewed. Eligibility, award amounts, and application requirements are unknown. Confirm deadline time and timezone with the issuing agency.
Official ESBD grants list retrieved 2026-09-09T21:57:06.050Z; grant number 542-AR_FY27.2_TRTA; status Posted.
Next action: Open the official ESBD grants listing, search by grant number, and contact the issuing agency to confirm requirements and deadline.
77/100 · Ok
evidence_quality reflects a federal-source baseline plus completeness of deadline, funding value, eligibility, and official-source fields on this specific record.
75/100 · Ok
confidence reflects OIP's confidence in its own interpretation of this record's lifecycle and funding-value status, not confidence that any applicant will qualify.
No numeric value · Not Applicable
potential_value is structurally not applicable for this Government category.
62/100 · Ok
urgency reflects the number of days remaining until the disclosed application deadline.
No numeric value · Insufficient Evidence
difficulty could not be scored: no application-complexity, preparation-burden, or applicant-cost evidence is available for this opportunity beyond generic boilerplate.
No numeric value · Insufficient Evidence
time_required could not be scored: no application-complexity, preparation-burden, or applicant-cost evidence is available for this opportunity beyond generic boilerplate.
No numeric value · Insufficient Evidence
capital_required could not be scored: no application-complexity, preparation-burden, or applicant-cost evidence is available for this opportunity beyond generic boilerplate.
Texas Regional Training Award
$.record.grantTitle · Field Mapping · 96/100 confidence
150 / 542-AR_FY27.2_TRTA
$.record.internalid · Field Mapping · 96/100 confidence
Cancer Prevention And Research Institute - 542
$.record.agencyName · Field Mapping · 94/100 confidence
Grant
request.body.urlRoot=esbd-grants · Field Mapping · 90/100 confidence
11/18/2026 5:00 PM; timezone unverified
$.record.applicationDeadline · Field Mapping · 92/100 confidence
Texas Regional Training Award
$.record.grantTitle · Field Mapping · 72/100 confidence
2026-08-05T00:00:00.000Z
$.record.postDate · Field Mapping · 86/100 confidence
2026-08-05T17:01:00.000Z
$.record.lastModified · Field Mapping · 86/100 confidence
Official source materials control eligibility, deadlines, amendments, attachments, and funding terms.
Open official source60/100 · Ok
risk reflects the number of material evidence gaps on this record (undisclosed value, missing deadline, unlisted eligibility, or a stale source date), not ordinary competitive uncertainty.
No numeric value · Insufficient Evidence
novelty could not be scored: no current Government source provides a reliable per-record signal for whether an opportunity is genuinely novel versus long-standing.